Health Canada approves Tagrisso with the addition of chemotherapy for patients with EGFR-mutated advanced lung cancer
Approval based on FLAURA2 results, which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly nine months compared to standard of care MISSISSAUGA, ON, July 12, 2024 /CNW/ - Health Canada has granted a Notice of …